Danone acquires Harrogate Water to diversify its product portfolio
By Akshay Kedari  Date: 2020-02-29

Danone acquires Harrogate Water to diversify its product portfolio

French food and drink company, Danone S.A. has recently made a strategic acquisition through its United Kingdom affiliate by acquiring majority shares in Harrogate Water, a UK-based bottled water company. Harrogate is best known for its charitable water brand Thirsty Planet and its regular water brand Harrogate Spring Water.

Report claim that current stakeholders of Harrogate Water, the Cain family, would go on to become minority shareholders of the company. Meanwhile, James Cain, CEO, Harrogate Water, would be a part of Danone Waters UK’s management team.

Speaking on the move, James Cain said that the company is excited to join Danone, the ideal business partner that would help Harrogate Water take striding steps while celebrating and respecting its heritage and history.

Moreover, both Harrogate Water and Danone share a similar approach and ethos to sustainability and community. Starting as a family business, Harrogate has made it clear that it derives inspiration from its colleagues, people, customers, and partners. Together with Danone’s team, the water company is confident to maintain its path to glory, with a like-minded, considered approach, added Cain.

As for James Pearson, Managing Director, Danone Waters UK & Ireland, the company is delighted to welcome Harrogate Water to its family. This acquisition would help it to fulfill the growing demand for on-the-go consumption & sparkling water as well as expanding its offering in the UK.

Situated in Paris, Danone has had a diverse range of bottled water varieties which consist of Actimel, Activia, Aptamil, Alpro, Danio, Danette, Danonino, Dannon, Nutricia, Evian, Volvic, and Nutrilon. However, Danone has lowered its profit margin and sales growth targets for 2020, as it anticipates negative business impacts follows the effects of Covid-19 (coronavirus) in the Chinese food & beverage market.

Reportedly, Danone and Diageo are one of the latest firms to issue a warning, stating the global epidemic known as coronavirus would hurt its profit and cost it millions in sales.

Source Credit: https://www.drinks-insight-network.com/news/danone-harrogate-water/

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Rivian secures USD 2.65 billion months before its first vehicle launch
Rivian secures USD 2.65 billion months before its first vehicle launch
By Akshay Kedari

Electric vehicle startup, Rivian, backed by Ford Motor Co. and Amazon.com Inc., has reportedly announced an investment round of USD 2.65 billion led by T. Rowe Price, months before its first vehicle launch. Sources with knowledge of the matter state...

BMW drivers can now unlock and start cars without using their iPhone
BMW drivers can now unlock and start cars without using their iPhone
By Akshay Kedari

German multinational automobile manufacturer, Bayerische Motoren Werke AG, commonly known as BMW, has reportedly unveiled an upgraded version of its mobile car key technology, called the Digital Key Plus. This product enables iPhone users to unlock t...

FMCG firms resort to marginal hike to cope with raw material inflation
FMCG firms resort to marginal hike to cope with raw material inflation
By Akshay Kedari

The recent inflation in raw materials has reportedly prompted players in the FMCG sector to take price hike measures for their products, in a bid to maintain the revenues. According to reliable sources, some FMCG companies, including Marico, have al...

boAt raises USD 100 million in funding from Warburg Pincus
boAt raises USD 100 million in funding from Warburg Pincus
By Akshay Kedari

Indian consumer electronics brand, boAt, has reportedly secured funding of USD 100 million from Warburg Pincus, a New-York-based private equity firm, at a USD 300 million valuation. The company will utilize these funds to expand its product portfoli...

Elevar Therapeutics and Inceptua partner to commercialize Apealea®
Elevar Therapeutics and Inceptua partner to commercialize Apealea®
By Akshay Kedari

According to reliable sources, U.S.-based fully integrated biopharmaceutical company, Elevar Therapeutics Inc., has signed an exclusive agreement with Inceptua Group for the commercialization and distribution of its non-cremophor based paclitaxel tre...